These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16956888)

  • 1. RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta-cells.
    Gan Z; Zhao L; Yang L; Huang P; Zhao F; Li W; Liu Y
    J Biol Chem; 2006 Nov; 281(44):33386-94. PubMed ID: 16956888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun amino-terminal kinase-1 mediates glucose-responsive upregulation of the RNA editing enzyme ADAR2 in pancreatic beta-cells.
    Yang L; Huang P; Li F; Zhao L; Zhang Y; Li S; Gan Z; Lin A; Li W; Liu Y
    PLoS One; 2012; 7(11):e48611. PubMed ID: 23139803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA editing of 5-HT
    Xie KY; Chien SJ; Tan BC; Chen YW
    FASEB J; 2021 Oct; 35(10):e21929. PubMed ID: 34553421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis.
    Yang L; Zhao L; Gan Z; He Z; Xu J; Gao X; Wang X; Han W; Chen L; Xu T; Li W; Liu Y
    FASEB J; 2010 Oct; 24(10):3720-32. PubMed ID: 20501795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
    Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
    Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
    FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.
    Kubota-Sakashita M; Iwamoto K; Bundo M; Kato T
    Mol Brain; 2014 Jan; 7():5. PubMed ID: 24443933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
    Keegan LP; Hajji K; O'Connell MA
    Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editing of messenger RNA precursors and of tRNAs by adenosine to inosine conversion.
    Keller W; Wolf J; Gerber A
    FEBS Lett; 1999 Jun; 452(1-2):71-6. PubMed ID: 10376681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The majority of A-to-I RNA editing is not required for mammalian homeostasis.
    Chalk AM; Taylor S; Heraud-Farlow JE; Walkley CR
    Genome Biol; 2019 Dec; 20(1):268. PubMed ID: 31815657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
    Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.
    Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH
    Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR RNA editing in human disease; more to it than meets the I.
    Gallo A; Vukic D; Michalík D; O'Connell MA; Keegan LP
    Hum Genet; 2017 Sep; 136(9):1265-1278. PubMed ID: 28913566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
    Mizrahi RA; Phelps KJ; Ching AY; Beal PA
    Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.